13 Jul 2009 17:29
For immediate release: 13 July 2009
Akers Biosciences, Inc.
(the "Company")
Result of Annual General Meeting
Akers Biosciences, Inc. (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that all resolutions proposed at the Annual General Meeting of the Company, held today, were duly passed.
For further information please contact:
Thomas A. Nicolette
President and CEO
Tel. +1 856 848 8698
Ben Simons
M: Communications
Tel. +44 (0)20 7153 1540
Alasdair Younie
Arbuthnot Securities Limited
Tel. +44 (0)20 7012 2000